Proton magnetic resonance spectroscopy of lenticular nuclei in simple schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 24, Issue 4, 2000, Pages 507-519

  Ohara, Koichi ^a,b   Isoda, Haruo ^a   Suzuki, Yasuo ^a   Takehara, Yasuo ^a   Ochiai, Masato ^a   Takeda, Hiroyasu ^a   Hattori, Koh ^a   Igarashi, Yukihiro ^a   Ohara, Kenshiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Shinshiro Municipal Hospital   (Japan)

Author keywords

Choline; Creatine; MRS; N acetyl aspartate; Proton; Schizophrenia

Indexed keywords

CHOLINE; N ACETYLASPARTIC ACID;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; BASAL GANGLION; BRAIN CELL; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOSOCIAL WITHDRAWAL; SCHIZOPHRENIA;

ADULT; CASE-CONTROL STUDIES; CORPUS STRIATUM; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTONS; SCHIZOPHRENIA;

EID: 0034190594     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(00)00089-0     Document Type: Article

References (31)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Press, Washington, D.C.
2. Barker, P.B., Breiter, S.N., Soher, B.J., Chatham, J.C., Forder, J.R., Samphilipo, M.A., Magee, C.A., and Anderson, J.H. (1994) Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn. Reson. Med. 32: 157-163.
3. Benes, F.M., Paskevich, P.A., Davidson, J., and Domesick, V.B. (1985) The effects of haloperidol on synaptic patterns in the rat striatum. Brain Res. 329: 265-274.
4. Bertolino, A., Nawroz, S., Mattay, V.S., Barnett, A.S., Duyn, J.H., Moonen, C.T.W., Frank, J.A., Tedeschi, G., and Weinberger, D.R. (1996) Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry 153: 1554-1563.
5. Besson, J.A., Corrigan, F.M., Cherryman, G.R., and Smith, F.W. (1987) Nuclear magnetic resonance brain imaging in chronic schizophrenia. Br. J. Psychiatry 150: 161-163.
6. Black, D.W., and Boffeli, T.J. (1989) Simple schizophrenia: Past, present, and future. Am. J. Psychiatry 146: 1267-1273.
7. Bleuler, E. (1911) Dementia Praecox, or the Group of Schizophrenias. Translated by Zinkin J. International University Press, New York (1950).
8. Buchsbaum, M.S., Wu, J.C., Delisi, L.E., Holocomb, H.H., Hazlett, E., Cooper-Langston, K., and Kessler. R. (1987) Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schizophrenic patients. Biol. Psychiatry 22: 479-494.
9. Buckley, P.F., Moore, C., Long, H., Larkin, C., Thompson, P., Mulvany, F., Redmond, O., Stack, J.P., Ennis, J.T., and Waddington, J.L. (1994) 1H Magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical neurodevelopmental and cognitive correlates. Biol. Psychiatry 36: 792-800.
10. Choe, B.Y., Kim, K.T., Suh, T.S., Lee, C., Paik, I.H., Bahk, Y.W., Shinn, K.S., and Lenkinski, R.E. (1994) 1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naive, chronic schizophrenia. Acad. Radiology 1: 211-216.
11. Early, T.S., Reiman, E.M., Raichle, M.E., and Spitznagel, E.L. (1987) Left globus pallidus abnormality in never-medicated patients with schizophrenia. Proc. Natl. Acad. Sci. USA 84: 561-563.
12. Elkashef, A.M., Buchanan, R.W., Gellad, F., Munson, R.C., and Breier, A. (1994) Basal ganglia pathology in schizophrenia and tardive dyskinesia: An MRI quantitative study. Am. J. Psychiatry 151: 752-755.
13. Endicott, J., and Spitzer, R.L. (1978) A diagnostic interview, the Schedule for Affective Disorders and Schizophrenia. Arch. Gen. Psychiatry 35: 837-844.
14. Falkai, P., and Bogerts, B. (1995) The neuropathology of schizophrenia. In: Schizophrenia, S.R. Hirsch and D.R. Weinberger (Eds.), pp. 275-292, Blackwell Science, London.
15. Fujimoto, T., Nakano, T., Takano, T., Takeuchi, K., Yamada, K., Fukuzako, T., and Akimoto, H. (1996) Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia. Biol. Psychiatry 40:14-18.
16. Fujimoto, T., Yokoyama, Y., Okada, A., Kanemaru, R., Kihara, Y., Watanabe, K., Asakura, T., and Igata, A. (1985) T1 measurement in schizophrenic disorders. Jpn. J. Med. Imag. 4: 1033-1039.
17. Gill, S.S., Small, R.K., Thomas, D.G.T., and Patel, P. (1989) Brain metabolites as 1H NMR markers of neuronal and glial disorders. NMR Biomed. 2: 196-200.
18. Harvey, I., Ron, M.A., Murray, R., Lewis, S., Barker, G., and McManus, D. (1991) MRI in schizophrenia: basal ganglia and white matter T1 times. Psychol. Med. 21: 587-598.
19. Heckers, S., Heinsen, H., Heinsen, Y., and Beckmann, H. (1991) Cortex, white matter, and basal ganglia in schizophrenia: A volumetric postmortem study. Biol. Psychiatry 29: 556-566.
20. Hoshino, Y., Yoshikawa, K., Inoue, Y., Asai, S., Nakamura, T., Ogino, T., Umeda, M., and Iwamoto, A. (1999) Reproducibility of short echo time proton magnetic resonance spectroscopy using point-resolved spatially localized spectroscopy sequence in normal human brains. Rad. Med. 17: 115-120.
21. Jernigan, T.L., Zisook, S., Heaton, R.K., Moranville, J.T., Hesselink, J.R., and Braff, D.L. (1991) Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. Arch. Gen. Psychiatry 48: 881-890.
22. Kaplan, H.I., and Sadock, B.J. (1998) Basal ganglia. In: Synopsis of Psychiatry, Eighth Edition, pp. 461-462, Williams & Wilkins, Baltimore.
23. Luchins, D.J., Metz, J.T., Marks, R.C., and Cooper, M.D. (1989) Basal ganglia regional glucose metabolism asymmetry during a catatonic episode. Biol. Psychiatry 26: 725-728.
24. Miller, B.L. (1991) A review of chemical issues in 1H NMR spectroscopy: N-acetylaspartate, creatine and choline. NMR Biomed. 4: 47-52.
25. Renshaw, P.F., Yurgelun-Todd, D.A., Tohen, M., Gruber, S., and Cohen, B.M. (1995) Temporal lobe proton magnetic resonance spectroscopy of patients with first-episodic psychosis. Am. J. Psychiatry 152: 444-446.
26. Sharma, R., Venkatasubramanian, P.N., Bàràny, M., and Davis, J.M. (1992) Proton magnetic resonance spectroscopy of the brain in schizophrenic and affective patients. Schizophr. Res. 8: 43-49.
27. 15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients. Lancet 2: 1448-1452.
28. Shioiri, T., Hamakawa, H., Kato, T., Murashita, J., Fujii, K., Inubushi, T., and Takahashi, S. (1996) Proton magnetic resonance spectroscopy of the basal ganglia in patients with schizophrenia: a preliminary report. Schizophr. Res. 22: 19-26.
29. Szechtman, H., Nahmias, C., Garnett, E.S., Fisnau, G., Brown, G.M., Kaplan, R.D., and Cleghorn, J.M. (1988) Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Arch. Gen. Psychiatry 45: 523-532.
30. Urenjak, J., Williams, S.R., Gadian, D.G., and Noble, M. (1993) Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J. Neurosci. 13:981-989.
31. World Health Organization (1993) The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. WHO.